Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001255294-10-000851
Filing Date
2010-10-07
Accepted
2010-10-06 19:12:20
Documents
4
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 MAINBODY mainbody.htm 10-K 686924
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 12462
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 12463
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 7504
  Complete submission text file 0001255294-10-000851.txt   720895
Mailing Address 1461 A. FIRST AVENUE, SUITE 360 NEW YORK NY 10021-2209
Business Address 1461 A. FIRST AVENUE, SUITE 360 NEW YORK NY 10021-2209 (646) 845-1920
Genova Biotherapeutics Inc. (Filer) CIK: 0001364587 (see all company filings)

EIN.: 204939361 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-52703 | Film No.: 101112677
SIC: 2834 Pharmaceutical Preparations